Latest Convertible Note Offer News

Dome Gold Mines Ltd is launching a $7 million convertible note offering aimed at funding key developments in its Fiji mining projects, including the Sigatoka feasibility study and exploration programs.

Osteopore Limited has drawn an additional A$250,000 under the first tranche of its redeemable convertible notes, continuing its steady capital raise to support growth and innovation.

Mesoblast has entered agreements to issue up to US$50 million in convertible notes, aiming to strengthen its capital base and support pipeline growth, pending shareholder approval.

Flight Centre Travel Group has priced a A$450 million convertible notes offering with a 2.5% coupon and a 37.5% conversion premium, while repurchasing A$225 million of existing notes to streamline its capital structure.

Flight Centre Travel Group has launched a A$450 million convertible notes offering due 2032, aiming to repurchase up to A$325 million of existing notes and support its growth ambitions with extended debt maturity.

Life360 reported record Q2 2025 results with robust subscription growth and raised full-year guidance, alongside a strategic leadership transition appointing Lauren Antonoff as CEO.

Clime Capital Limited has launched a new Convertible Redeemable Notes offer featuring a 6.5% fixed annual interest rate, providing investors with monthly income and conversion flexibility.

Clime Capital Limited (ASX, CAM) has announced a $14 million convertible note offer featuring a 6.5% fixed interest rate and a maturity date in 2028. The notes are convertible into ordinary shares on a one-for-one basis, providing investors with a hybrid income and equity exposure.

Genmin Limited’s latest quarterly cash flow report reveals significant cash outflows and a critical liquidity shortfall, prompting urgent funding measures including new loans and convertible notes.

Top Shelf International Holdings is set to raise up to $10 million through convertible notes to support a strategic business restructure and operational improvements, alongside forging a key sales partnership with Amber Bev.

Pilot Energy has issued $600,000 in convertible notes under a previously approved $1.8 million facility with Discovery Investments, correcting a minor contractual reference without altering terms.

Paradigm Biopharmaceuticals has locked in a $27 million USD convertible note facility to fully fund its pivotal Phase 3 trial for knee osteoarthritis, ensuring operational momentum through key clinical milestones.